Squarepoint
IMCR icon

Squarepoint’s Immunocore IMCR Stock Holding History

Squarepoint’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Sell
11,746
-3,688
-24% -$109K ﹤0.01% 3660
2026
Q1 		$465K Buy
15,434
+46
+0.3% +$1.49K ﹤0.01% 3377
2025
Q4 		$534K Buy
+15,388
New +$543K ﹤0.01% 3160
2025
Q3 		– Sell
-10,714
Closed -$336K – 4639
2025
Q2 		$336K Buy
+10,714
New +$333K ﹤0.01% 3601
2025
Q1 		– Sell
-69,954
Closed -$2.06M – 4973
2024
Q4 		$2.06M Sell
69,954
-2,114
-3% -$66.8K ﹤0.01% 2384
2024
Q3 		$2.24M Sell
72,068
-1,698
-2% -$61.8K ﹤0.01% 1988
2024
Q2 		$2.5M Buy
73,766
+70,648
+2,266% +$3.6M ﹤0.01% 1875
2024
Q1 		$203K Buy
+3,118
New +$214K ﹤0.01% 3614
2023
Q4 		– Sell
-4,738
Closed -$246K – 4232
2023
Q3 		$246K Sell
4,738
-1,528
-24% -$90.4K ﹤0.01% 3287
2023
Q2 		$376K Sell
6,266
-12,764
-67% -$729K ﹤0.01% 2823
2023
Q1 		$941K Buy
19,030
+5,696
+43% +$320K ﹤0.01% 1940
2022
Q4 		$761K Buy
13,334
+7,734
+138% +$435K ﹤0.01% 2021
2022
Q3 		$263K Buy
+5,600
New +$267K ﹤0.01% 2556

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Squarepoint's IMCR Position: Q2 2026 in Review

Squarepoint reduced its Immunocore (IMCR) stake by 24% in Q2 2026, selling an estimated $109K and leaving 11,746 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Squarepoint first reported a position in IMCR in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.5M in Q2 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Squarepoint held 11,746 shares of Immunocore worth $373K as of Q2 2026.
  • Squarepoint sold 3,688 Immunocore shares in Q2 2026, an estimated $109K.
  • Immunocore made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3660 holding.
  • Squarepoint first reported a position in Immunocore in Q3 2022 and has held it in 13 quarters since.
  • Squarepoint's Immunocore position peaked at $2.5M in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.